Jasper Hellweg
Stock Analyst at Argus Research
(1.64)
# 1597
Out of 5,231 analysts
102
Total ratings
54.00%
Success rate
14.48%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
United Therapeutics | Maintains: Strong Buy | 360 400 | 372.75 | 7.31% | 6 | Oct 31, 2024 | |
Illumina | Upgrades: Buy | 150 | 131.74 | 13.86% | 7 | Aug 28, 2024 | |
Sanofi | Maintains: Strong Buy | 55 60 | 52.37 | 14.57% | 2 | Jul 26, 2024 | |
Regeneron Pharmaceut... | Maintains: Strong Buy | 1060 1170 | 686.8 | 70.36% | 7 | Jun 25, 2024 | |
Vertex Pharmaceutica... | Maintains: Strong Buy | 465 550 | 441.91 | 24.46% | 6 | Jun 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 80 85 | 70.28 | 20.94% | 3 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 115 125 | 84.05 | 48.72% | 1 | Feb 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 160 140 | 40.77 | 243.39% | 4 | Sep 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jul 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 320 350 | 144.44 | 142.32% | 3 | May 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Apr 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 225 200 | 170.31 | 17.43% | 5 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Apr 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 475 500 | n/a | n/a | 2 | Feb 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Jan 27, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 290 | 197.94 | 46.51% | 4 | Sep 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 100 | 143.48 | -30.3% | 3 | Jun 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 270 295 | 246.44 | 19.7% | 4 | May 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | May 5, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 135 | 155.27 | -13.05% | 5 | Oct 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 4, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Apr 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Jan 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Oct 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Nov 15, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 150 155 | 327.75 | -52.71% | 3 | Nov 6, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 90 | 212.89 | -57.72% | 1 | Sep 19, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 154 110 | n/a | n/a | 1 | May 2, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 45 0 | n/a | n/a | 2 | Apr 25, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 98 104 | n/a | n/a | 1 | Sep 18, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Jul 7, 2017 |